Huami Corporation American Depositary Shares, each representing four Class A Ordinary Shares (HMI) News
Filter HMI News Items
HMI News Results
|Loading, please wait...|
HMI News Highlights
- HMI's 30 day story count now stands at 10.
- Over the past 29 days, the trend for HMI's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about HMI are GTS.
Latest HMI News From Around the Web
Below are the latest news stories about Huami Corp that investors may wish to consider to help them evaluate HMI as an investment opportunity.
Zepp Health Corp. to Report Fourth Quarter and Full Year 2020 Financial Results on March 15, 2021
Zepp Health Corp. ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its fourth quarter and full year 2020 unaudited financial results before the market open on Monday, March 15, 2021.
Huami Corporation Announces Name Change to Zepp Health
Huami Corp. today announced it is changing its name internationally to Zepp Health Corp. (NYSE: ZEPP) and the ticker symbol of its American depositary shares listed on the NYSE to "ZEPP" to better reflect its deepening commitment to connecting health with technology, expansion of its current product portfolio and its growth in serving the industrial healthcare technology market. Additionally, "Zepp" is a name that is easy to remember, transcending languages, cultures and borders.
Huami Corp Invests $5 Million in Hyperfine Research D Round to Support Accelerated Application of Disruptive MRI Technology
BEIJING & CUPERTINO, Calif.--(BUSINESS WIRE)--Huami Corp. (NYSE: HMI) today announced that it has invested $5 million in Hyperfine Research’s D round of funding, which closed on February 3, 2021. Huami’s mission is to connect health with technology, developing both consumer and industrial health technologies. The company believes its miniaturization engineering expertise dovetails with efforts to miniaturize medical imaging technology which can disrupt the locations, applications and costs of m
Keep Hearts Healthy This Valentine’s Day with Amazfit Smartwatches
Amazfit Valentine's Day Sale
Amazfit GTS 2 review
The Amazfit GTS 2 is another budget smartwatch from Huami, but with affordable options from Apple and Fitbit better than ever, is it enough?
Amazfit GTR 2 review: Beautifully designed smartwatch with positives outweighing negatives
Sleek. It’s an adjective that just recurs when one looks at all of Huami’s smartwatch options, whether it is its Zepp brand or indeed the Amazfit GTR 2 and GTS 2.
Zepp Z review
The Zepp Z is the Huami sub-brand's second smartwatch, but does it do enough to justify the premium price tag?
Amazfit GTS 2 review – feature-rich, but there’s still room for improvement
Huami has launched the Amazfit GTS 2 smartwatch in India with a price tag of ₹12,999. The Amazfit GTS 2 features blood oxygen saturation (SpO2) monitor, heart
Huami to Host 2021 Strategy and Outlook Investor Fireside Chat with CEO Wang Huang on January 22
Huami Corp. (NYSE: HMI) today announced that it will hold a Fireside Chat conference call for investors on Friday, 22 January 2021. The company will discuss its 2021 strategies for consumer and industrial health technologies, including its product plans announced at the Consumer Electronics Show and new partnerships in medical imaging. Speakers will include Chairman, CEO and founder, Wang Huang; CFO Leon Deng; and COO Mike Yeung.
Promaxo Raises $4.17M in Funding Round Led by Huami Corporation
OAKLAND, Calif. & CUPERTINO, Calif.--(BUSINESS WIRE)--Promaxo, Inc. (Promaxo), the medical imaging, robotics, and AI technology company, and Huami Corp. (NYSE: HMI) today announced closing an investment round of $4.17M led by Huami. “As an industry, we are just scratching the surface of how powerful MRI is poised to become in guided interventions, and we are proud to have Huami as a strategic investor as we introduce our truly open MRI system to the masses,” said Dr. Amit Vohra, founder and CEO